Long‐term efficacy of the sodium–glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome

Type A insulin resistance (IR) syndrome is a severe IR form caused by insulin receptor (INSR) gene defects. Antidiabetic drugs, including high‐dose insulin and insulin‐sensitizing agents, often fail to control associated hyperglycemia. Therapy with recombinant human insulin‐like growth factor 1 can...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagashima, Shuichi, Wakabayashi, Tetsuji, Saito, Naoko, Takahashi, Manabu, Okada, Kenta, Ebihara, Ken, Ishibashi, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477530/
https://www.ncbi.nlm.nih.gov/pubmed/32100949
http://dx.doi.org/10.1111/jdi.13241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477530/
https://www.ncbi.nlm.nih.gov/pubmed/32100949
http://dx.doi.org/10.1111/jdi.13241

Ejemplares similares